{"id":"https://openalex.org/W4413775835","doi":"https://doi.org/10.1016/s2152-2650(25)00492-6","title":"POSTER: AML-117 A Phase 1b Study of Selinexor and Venetoclax in Patients With Relapsed or Refractory Acute Myeloid Leukemia","display_name":"POSTER: AML-117 A Phase 1b Study of Selinexor and Venetoclax in Patients With Relapsed or Refractory Acute Myeloid Leukemia","publication_year":2025,"publication_date":"2025-08-28","ids":{"openalex":"https://openalex.org/W4413775835","doi":"https://doi.org/10.1016/s2152-2650(25)00492-6"},"language":"en","primary_location":{"id":"doi:10.1016/s2152-2650(25)00492-6","doi":"https://doi.org/10.1016/s2152-2650(25)00492-6","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s2152-2650(25)00492-6","pdf_url":null,"source":{"id":"https://openalex.org/S186546955","display_name":"Clinical Lymphoma Myeloma & Leukemia","issn_l":"2152-2650","issn":["2152-2650","2152-2669"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Lymphoma Myeloma and Leukemia","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5040675080","display_name":"Somedeb Ball","orcid":"https://orcid.org/0000-0002-1754-1204","observed_orcids":["https://orcid.org/0000-0002-1754-1204"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]},{"id":"https://openalex.org/I4390039299","display_name":"Vanderbilt-Ingram Cancer Center","ror":"https://ror.org/02rjj2m04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I4390039299","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Somedeb Ball","raw_affiliation_strings":["Vanderbilt Ingram Cancer Center, Nashville, TN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt Ingram Cancer Center, Nashville, TN, USA","institution_ids":["https://openalex.org/I200719446","https://openalex.org/I4390039299"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040815890","display_name":"Michael Thomas Byrne","orcid":"https://orcid.org/0000-0002-2966-4877","observed_orcids":["https://orcid.org/0000-0002-2966-4877"]},"institutions":[{"id":"https://openalex.org/I4210135086","display_name":"Tennessee Oncology","ror":"https://ror.org/03754ky26","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210135086"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael T. Byrne","raw_affiliation_strings":["Tennessee Oncology, Nashville, TN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tennessee Oncology, Nashville, TN, USA","institution_ids":["https://openalex.org/I4210135086"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Melissa A. Fischer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]},{"id":"https://openalex.org/I4390039299","display_name":"Vanderbilt-Ingram Cancer Center","ror":"https://ror.org/02rjj2m04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I4390039299","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Melissa A. Fischer","raw_affiliation_strings":["Vanderbilt Ingram Cancer Center, Nashville, TN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt Ingram Cancer Center, Nashville, TN, USA","institution_ids":["https://openalex.org/I200719446","https://openalex.org/I4390039299"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059854479","display_name":"Farrukh Tauseef Awan","orcid":"https://orcid.org/0000-0003-1813-9812","observed_orcids":["https://orcid.org/0000-0003-1813-9812"]},"institutions":[{"id":"https://openalex.org/I867280407","display_name":"The University of Texas Southwestern Medical Center","ror":"https://ror.org/05byvp690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I867280407"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Farrukh T. Awan","raw_affiliation_strings":["University of Texas Southwestern Medical Center, Dallas, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas Southwestern Medical Center, Dallas, TX, USA","institution_ids":["https://openalex.org/I867280407"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082911627","display_name":"Benjamin Kent Tomlinson","orcid":"https://orcid.org/0000-0002-2407-0973","observed_orcids":["https://orcid.org/0000-0002-2407-0973"]},"institutions":[{"id":"https://openalex.org/I2799343972","display_name":"University Hospitals of Cleveland","ror":"https://ror.org/0130jk839","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799343972"]},{"id":"https://openalex.org/I4210119077","display_name":"University Hospitals Seidman Cancer Center","ror":"https://ror.org/02kb97560","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799343972","https://openalex.org/I4210119077"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Benjamin K. Tomlinson","raw_affiliation_strings":["University Hospitals Seidman Cancer Center, Cleveland, OH, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Hospitals Seidman Cancer Center, Cleveland, OH, USA","institution_ids":["https://openalex.org/I2799343972","https://openalex.org/I4210119077"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056037255","display_name":"Tess Stopczynski","orcid":"https://orcid.org/0000-0001-5530-5045","observed_orcids":["https://orcid.org/0000-0001-5530-5045"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]},{"id":"https://openalex.org/I4390039299","display_name":"Vanderbilt-Ingram Cancer Center","ror":"https://ror.org/02rjj2m04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I4390039299","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tess Stopczynski","raw_affiliation_strings":["Vanderbilt Ingram Cancer Center, Nashville, TN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt Ingram Cancer Center, Nashville, TN, USA","institution_ids":["https://openalex.org/I200719446","https://openalex.org/I4390039299"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Lokesh Patil","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210130485","display_name":"Notable Labs (United States)","ror":"https://ror.org/03b9h7664","country_code":"US","type":"company","lineage":["https://openalex.org/I4210130485"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lokesh Patil","raw_affiliation_strings":["Notable Labs, Foster City, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Notable Labs, Foster City, CA, USA","institution_ids":["https://openalex.org/I4210130485"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031373184","display_name":"Christine J. Gu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210130485","display_name":"Notable Labs (United States)","ror":"https://ror.org/03b9h7664","country_code":"US","type":"company","lineage":["https://openalex.org/I4210130485"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christine J. Gu","raw_affiliation_strings":["Notable Labs, Foster City, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Notable Labs, Foster City, CA, USA","institution_ids":["https://openalex.org/I4210130485"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Chris Leonardi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210130485","display_name":"Notable Labs (United States)","ror":"https://ror.org/03b9h7664","country_code":"US","type":"company","lineage":["https://openalex.org/I4210130485"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chris Leonardi","raw_affiliation_strings":["Notable Labs, Foster City, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Notable Labs, Foster City, CA, USA","institution_ids":["https://openalex.org/I4210130485"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112210889","display_name":"Katherine Jean Walsh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]},{"id":"https://openalex.org/I4390039299","display_name":"Vanderbilt-Ingram Cancer Center","ror":"https://ror.org/02rjj2m04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I4390039299","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Katherine J. Walsh","raw_affiliation_strings":["Vanderbilt Ingram Cancer Center, Nashville, TN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt Ingram Cancer Center, Nashville, TN, USA","institution_ids":["https://openalex.org/I200719446","https://openalex.org/I4390039299"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013233073","display_name":"Gregory Dan Ayers","orcid":"https://orcid.org/0000-0002-0892-350X","observed_orcids":["https://orcid.org/0000-0002-0892-350X"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]},{"id":"https://openalex.org/I4390039299","display_name":"Vanderbilt-Ingram Cancer Center","ror":"https://ror.org/02rjj2m04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I4390039299","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gregory Dan Ayers","raw_affiliation_strings":["Vanderbilt Ingram Cancer Center, Nashville, TN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt Ingram Cancer Center, Nashville, TN, USA","institution_ids":["https://openalex.org/I200719446","https://openalex.org/I4390039299"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061478349","display_name":"Ashwin Kishtagari","orcid":"https://orcid.org/0000-0003-1149-4571","observed_orcids":["https://orcid.org/0000-0003-1149-4571"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]},{"id":"https://openalex.org/I4390039299","display_name":"Vanderbilt-Ingram Cancer Center","ror":"https://ror.org/02rjj2m04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I4390039299","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ashwin Kishtagari","raw_affiliation_strings":["Vanderbilt Ingram Cancer Center, Nashville, TN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt Ingram Cancer Center, Nashville, TN, USA","institution_ids":["https://openalex.org/I200719446","https://openalex.org/I4390039299"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085208978","display_name":"Kateryna Fedorov","orcid":"https://orcid.org/0009-0004-8876-8926","observed_orcids":["https://orcid.org/0009-0004-8876-8926"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]},{"id":"https://openalex.org/I4390039299","display_name":"Vanderbilt-Ingram Cancer Center","ror":"https://ror.org/02rjj2m04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I4390039299","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kateryna Fedorov","raw_affiliation_strings":["Vanderbilt Ingram Cancer Center, Nashville, TN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt Ingram Cancer Center, Nashville, TN, USA","institution_ids":["https://openalex.org/I200719446","https://openalex.org/I4390039299"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019176812","display_name":"Markus Daniel Lacher","orcid":"https://orcid.org/0000-0003-2597-5704","observed_orcids":["https://orcid.org/0000-0003-2597-5704"]},"institutions":[{"id":"https://openalex.org/I4210130485","display_name":"Notable Labs (United States)","ror":"https://ror.org/03b9h7664","country_code":"US","type":"company","lineage":["https://openalex.org/I4210130485"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Markus D. Lacher","raw_affiliation_strings":["Notable Labs, Foster City, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Notable Labs, Foster City, CA, USA","institution_ids":["https://openalex.org/I4210130485"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Joseph Wagner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210130485","display_name":"Notable Labs (United States)","ror":"https://ror.org/03b9h7664","country_code":"US","type":"company","lineage":["https://openalex.org/I4210130485"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph Wagner","raw_affiliation_strings":["Notable Labs, Foster City, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Notable Labs, Foster City, CA, USA","institution_ids":["https://openalex.org/I4210130485"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051485142","display_name":"Sanjay Ram Mohan","orcid":"https://orcid.org/0000-0002-6715-6697","observed_orcids":["https://orcid.org/0000-0002-6715-6697"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]},{"id":"https://openalex.org/I4390039299","display_name":"Vanderbilt-Ingram Cancer Center","ror":"https://ror.org/02rjj2m04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I4390039299","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sanjay R. Mohan","raw_affiliation_strings":["Vanderbilt Ingram Cancer Center, Nashville, TN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt Ingram Cancer Center, Nashville, TN, USA","institution_ids":["https://openalex.org/I200719446","https://openalex.org/I4390039299"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5049400849","display_name":"Michael Robert Savona","orcid":"https://orcid.org/0000-0003-3763-5504","observed_orcids":["https://orcid.org/0000-0003-3763-5504"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]},{"id":"https://openalex.org/I4390039299","display_name":"Vanderbilt-Ingram Cancer Center","ror":"https://ror.org/02rjj2m04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I4390039299","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael R. Savona","raw_affiliation_strings":["Vanderbilt Ingram Cancer Center, Nashville, TN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt Ingram Cancer Center, Nashville, TN, USA","institution_ids":["https://openalex.org/I200719446","https://openalex.org/I4390039299"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":7,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3890,"currency":"USD","value_usd":3890},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.23946649,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"25","issue":null,"first_page":"S181","last_page":"S181"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.98580002784729,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.98580002784729,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.002300000051036477,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/selinexor","display_name":"selinexor","score":0.9760000109672546},{"id":"https://openalex.org/keywords/venetoclax","display_name":"venetoclax","score":1.0},{"id":"https://openalex.org/keywords/relapsed-refractory-acute-myeloid-leukemia","display_name":"relapsed/refractory acute myeloid leukemia","score":0.9369999766349792},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7289999723434448},{"id":"https://openalex.org/keywords/bcl2-inhibitors","display_name":"BCL-2 inhibitor","score":0.5059999823570251},{"id":"https://openalex.org/keywords/xpo1-inhibitor","display_name":"XPO1 inhibitor","score":0.621999979019165}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9347394108772278},{"id":"https://openalex.org/C2779675984","wikidata":"https://www.wikidata.org/wiki/Q23671272","display_name":"Venetoclax","level":4,"score":0.8804945945739746},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.7774441242218018},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.6369070410728455},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.42480528354644775},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.40935730934143066},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.37699487805366516},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3607577681541443},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.0},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/s2152-2650(25)00492-6","doi":"https://doi.org/10.1016/s2152-2650(25)00492-6","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s2152-2650(25)00492-6","pdf_url":null,"source":{"id":"https://openalex.org/S186546955","display_name":"Clinical Lymphoma Myeloma & Leukemia","issn_l":"2152-2650","issn":["2152-2650","2152-2669"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Lymphoma Myeloma and Leukemia","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4413809968","https://openalex.org/W7204698931","https://openalex.org/W4413791117","https://openalex.org/W7204715281","https://openalex.org/W4413810840","https://openalex.org/W4413813178","https://openalex.org/W7204683405","https://openalex.org/W7204733637","https://openalex.org/W4413780387","https://openalex.org/W4413780179"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2025-10-10T00:00:00"}